Fusion Antibodies partner with A-Frontier to deliver services to South Korea

Fusion Antibodies have named A-Frontier as their exclusive supplier in South Korea enabling Biotech companies to access premium antibody discovery and engineering and cell line development services from a trusted supplier.

Fusion Antibodies have been delivering services for drug discovery companies for over 20 years and have developed several proprietary platforms for Humanization and Affinity Maturation.

A-Frontier is a leading supplier in Korea distributing diverse products and service, and have their own R&D center delivering custom antibody and protein related service.

This new partnership will strengthen Fusion Antibodies’ presence in the Asia- Pacific region and build upon existing collaborations in South Korea, Japan and China.

Paul Kerr, CEO, Fusion Antibodies said, “We are delighted to announce this partnership with A-Frontier. We recognize their quality organization and service provision; and extensive network in the Biotech field and are excited to have our platforms offered to their customers. This partnership will connect us with companies carrying out innovative work in drug discovery in South Korea. We look forward to working closely with companies to help them get to the clinic as quickly as possible without compromising the quality of their antibody.”

Eonjung Kim, CEO, A-Frontier said, “We are pleased to be able to offer these unrivalled platforms to our customers and are happy that Fusion Antibodies have selected us to deliver their services in this region.”